1800-272-662
Shopping Cart 0
countryflagAU
Login

Heramed Ltd

Healthcare AU HMD

0.044AUD
-(-%)

Last update at 2026-03-13T04:03:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.00650.05
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap49.00M
  • Volume1880384
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.82375M
  • Revenue TTM0.43M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.05M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -2.75703M -3.39826M -4.61776M -4.88066M -5.70894M
Minority interest - - - - -
Net income -2.75703M -3.39826M -4.50277M -6.61857M -7.38291M
Selling general administrative - 1.63M 1.70M 1.71M 1.73M
Selling and marketing expenses - 1.22M 1.13M 0.50M 0.46M
Gross profit - 0.14M 0.25M 0.14M 0.04M
Reconciled depreciation - 0.33M 0.44M 0.36M 0.27M
Ebit -2.65870M -3.37403M -4.41313M -3.14275M -3.93894M
Ebitda -2.56271M -3.34919M -3.97206M -2.78434M -3.66724M
Depreciation and amortization 0.10M 0.02M 0.44M 0.36M 0.27M
Non operating income net other - - - - -
Operating income -2.65871M -5.56831M -4.54558M -3.14275M -3.93894M
Other operating expenses 2.85M 5.93M 4.96M 3.40M 4.03M
Interest expense 0.00281M 0.05M 0.09M 1.74M 1.67M
Tax provision - 0.00000M 0.00000M 0.00000M 0.00000M
Interest income - 0.00913M 0.02M 0.04M 1.67M
Net interest income - -0.03916M -0.07038M -1.69978M -1.67389M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - 0.00000M 1.74M 1.67M
Total revenue 0.20M 0.23M 0.41M 0.22M 0.09M
Total operating expenses 2.76M 5.79M 4.79M 3.32M 3.98M
Cost of revenue - 0.09M 0.17M 0.08M 0.04M
Total other income expense net -0.09833M -0.02424M -0.07218M -1.73791M -1.77001M
Discontinued operations - - - - -
Net income from continuing ops - -5.49058M -4.50277M -4.88066M -5.70894M
Net income applicable to common shares - -5.49058M -6.77517M -4.88066M -5.70894M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.99M 2.78M 2.95M 4.16M 4.59M
Intangible assets - 0.73M - 1.04M 0.67M
Earning assets - - - - -
Other current assets 0.02M 0.09M - - 0.04M
Total liab 0.22M 1.06M 2.27M 1.30M 4.70M
Total stockholder equity 0.62M 1.72M 0.68M 2.86M -0.10598M
Deferred long term liab - - - 1.04M 0.67M
Other current liab 0.14M 0.41M 0.05M 0.05M 0.03M
Common stock 27.66M 24.10M 35.33M 22.16M 16.48M
Capital stock - 38.93M - 22.16M 16.48M
Retained earnings -29.48384M -28.67499M -42.12226M -24.23935M -19.35869M
Other liab - - - 0.50M 0.55M
Good will - - - - -
Other assets - - 0.00000M 1.04M 0.67M
Cash 0.91M 1.94M 1.06M 2.62M 3.56M
Cash and equivalents - - - - -
Total current liabilities 0.22M 0.65M 1.51M 0.79M 4.15M
Current deferred revenue - - 0.00000M - -
Net debt -0.91465M -1.88558M -0.79935M -2.43849M -0.14091M
Short term debt - 0.05M 0.26M 0.18M 3.42M
Short long term debt - 0.16M - 0.18M 3.42M
Short long term debt total - 0.05M 0.26M 0.18M 3.42M
Other stockholder equity - -0.00000M 0.00000M 0.09M 2.77M
Property plant equipment - - - 0.08M 0.03M
Total current assets 0.97M 2.30M 1.93M 3.04M 3.89M
Long term investments - - - - -
Net tangible assets - - - 2.86M -0.77634M
Short term investments - 0.02M - 0.02M 0.03M
Net receivables 0.03M 0.02M 0.50M 0.25M 0.24M
Long term debt - 0.66M - - 0.00000M
Inventory - 0.23M 0.36M 0.17M 0.09M
Accounts payable 0.07M 0.19M 1.20M 0.56M 0.69M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.45M 6.29M 7.47M 4.94M 2.77M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.03M 0.45M 0.95M - 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 0.03M 0.48M 1.03M 1.11M 0.70M
Capital lease obligations - - - - -
Long term debt total - - - 0.00000M 0.00000M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00000M -0.00139M -0.69078M -0.08543M
Change to liabilities - - - 0.00000M 0.19M
Total cashflows from investing activities - 0.00000M -0.00205M -0.69078M -0.08543M
Net borrowings - -0.20469M - -0.10290M 1.69M
Total cash from financing activities 1.27M 6.88M 2.96M 2.54M 4.88M
Change to operating activities - - - - -
Net income -2.75703M -3.39826M -4.49774M -6.61857M -5.70894M
Change in cash -1.17308M 1.21M -2.77901M -0.94238M 1.66M
Begin period cash flow 2.09M 0.72M 2.62M 3.56M 1.90M
End period cash flow 0.91M 1.94M 0.72M 2.62M 3.56M
Total cash from operating activities -2.44066M -4.81440M -5.57237M -6.26016M -3.23179M
Issuance of capital stock - 7.08M 2.12M 2.64M 3.31M
Depreciation 0.10M 0.20M 0.66M 0.36M 0.27M
Other cashflows from investing activities - - -0.00065M - -
Dividends paid - - - - -
Change to inventory - -0.00828M -0.10179M - -0.01922M
Change to account receivables 0.05M 0.18M -0.08867M - -0.00840M
Sale purchase of stock - 7.08M 3.19M 2.64M 3.31M
Other cashflows from financing activities - -0.07800M 0.95M -0.10290M 1.69M
Change to netincome - - - - 2.21M
Capital expenditures 0.00000M 0.00000M 0.00205M 0.69M 0.09M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.35880M 0.17M -0.10183M 0.02M 0.00048M
Stock based compensation - 0.22M 0.02M - -
Other non cash items 0.58M -2.01234M -0.99742M 6.26M 5.44M
Free cash flow -2.44066M -2.97976M -5.57442M -6.95094M -3.31721M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HMD
Heramed Ltd		 - -% 0.04 - - 113.53 52.63 163.31 -7.8401
COH
Cochlear Ltd		 -4.74 2.65% 174.42 33.10 26.39 4.88 6.04 5.59 23.13
4DX
4DMEDICAL Ltd		 -0.15 3.55% 4.07 - - 401.92 37.59 417.71 -7.2899
AVR
Anteris Technologies Global Corp		 - -% 9.10 - - 475.96 166.77 334.65 -5.1986
PNV
Polynovo Ltd		 - -% 0.94 94.00 30.21 4.66 7.81 4.68 93.96

Reports Covered

Stock Research & News

View All

Profile

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.

Heramed Ltd

117 Camberwell Road, Hawthorn East, VIC, Australia, 3123

Key Executives

Name Title Year Born
Mr. David Groberman Co-Founder, CEO & Exec. Director NA
Mr. Tal Slonim Co-Founder, COO & Exec. Director NA
Ms. Sivan Sadan Chief Financial Officer NA
Mr. Michael Nenner Chief Technology Officer NA
Henry Jordan Head of Investor Relations NA
Mr. Ariel Laden VP of Marketing NA
Dr. Josef Tovbin Chief Medical Officer NA
Mr. Jonathan Hart B.Com., L.L.B. Company Sec. NA
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. Executive Chairman NA
Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D. Executive Chairman NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.